With total assets of $53.7 billion, FWD Group has launched its fourth IPO attempt in Hong Kong, tapping into surging investor interest following battery giant CATL’s landmark listing.

FWD Group Holdings Ltd., an insurer backed by billionaire Richard Li, filed a fresh application for an initial public offering in Hong Kong.

Shares in China’s Contemporary Amperex Technology (CATL), the world’s largest electric vehicle battery maker, have surged as much as 18% on its first day of trading in Hong Kong, shrugging off geopolitical uncertainties.

Finance chief says city must continue to leverage advantages, as he reveals stock market has outperformed other major indices so far this year.

Chinese biotech company Bliss Biopharmaceutical (BlissBio) is reportedly considering a Hong Kong initial public offering (IPO) that could raise at least $150 million, according to Bloomberg sources. The

Chinese drug developer and producer Jiangsu Hengrui Pharmaceuticals is aiming to raise up to HK$9.89 billion ($1.27 billion) in a Hong Kong listing, according to a regulatory filing made on Thursday.

Pfizer and RemeGen's HER2 antibody-drug conjugate delivered positive phase 3 results in a bladder cancer trial in China. | Pfizer and RemeGen's HER2 ADC delivered positive phase 3 results in a bladder cancer trial in China.